1.
Gil A, Reyes Abad M, Alerany C, Alsina L, López Granados E, Neth O, Poveda JL, Rivière JG, Rodríguez-Gallego C, Tutein Nolthenius JB, Figueiredo R, Subías Labazuy S. Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders. Grhta [Internet]. 2024 May 22 [cited 2024 Nov. 5];11(1):124-30. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3041